134 filings
Page 2 of 7
POS AM
nilejlb
12 Apr 24
Prospectus update (post-effective amendment)
4:15pm
8-K
a0cxad
1 Apr 24
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
8:16am
424B3
x32vx
12 Mar 24
Prospectus supplement
4:18pm
EFFECT
d0u91e63so014
11 Mar 24
Notice of effectiveness
12:15am
8-K
9yq 5khzmnd
4 Mar 24
Regulation FD Disclosure
8:06am
POS AM
phjlv
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
8-K
yq11dlf6gpyxvc80j
28 Feb 24
NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update
8:11am
10-K
5lzp1zd kbvm
28 Feb 24
Annual report
8:00am
8-K
qhwob ss3l
15 Feb 24
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
4:18pm
424B5
7585ugbo
15 Feb 24
Prospectus supplement for primary offering
4:15pm
424B5
a036gp537tby
13 Feb 24
Prospectus supplement for primary offering
5:19pm
8-K
fesd6pr13pqbqnjfe67d
22 Jan 24
Regulation FD Disclosure
8:01am
8-K
yvsga 2zz5m6pcs
8 Jan 24
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8:21am
8-K
98cbon07b 2n04z
4 Jan 24
NewAmsterdam Pharma Announces 2024 Strategic Priorities
8:08am
EFFECT
9he8ua8 0uq
20 Dec 23
Notice of effectiveness
12:15am
424B3
gz1jzcw
19 Dec 23
Prospectus supplement
4:36pm
UPLOAD
9evt6 repi
15 Dec 23
Letter from SEC
12:00am
CORRESP
44pmn
15 Dec 23
Correspondence with SEC
12:00am
F-3
757m by9svyeskcsy0
7 Dec 23
Shelf registration (foreign)
4:16pm
424B3
t4580 1qq
13 Nov 23
Prospectus supplement
8:24am